logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO 2018—French study shows sunitinib alone as good as cytoreductive nephrectomy + sunitinib for metastatic renal cell carcinoma

Cytoreductive nephrectomy with adjuvant systemic therapy has been the standard of care for 2 decades.